Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
Details for Australian Patent Application No. 2005239833 (hide)
International Classifications
Event Publications
16 November 2006 PCT application entered the National Phase
PCT publication WO2005/107754 Priority application(s): WO2005/107754
12 November 2009 Amendment Made
The nature of the amendment is: Amend the name of the inventor to add co-inventors Van Scharrenburg, J.M. and Teunissen, Hendrik
25 February 2010 Application Accepted
Published as AU-B-2005239833
24 June 2010 Standard Patent Sealed
18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005239836-Benzylidene-beta-&bgr;-dicarbonyl compounds as novel UV-absorbers
2005239832-Method to fight against insects including the use of hydrocarbon compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser